Angiogenesis is the creation of new blood vessels, a process that occurs in both health and disease. When new tissue is formed, as in the healing of a wound or the creation of the placenta, blood vessel formation must occur as well. The body is awash in factors that act to signal the growth and differentiation of various cells, including those of the arteries and veins, and the arterioles, venules, and capillaries. The control of angiogenesis operates through a series of “on” and “off” switches that either stimulate or inhibit the formation of new vessels. If there are too many “ons” and insufficient “offs,” the upset of balance favors the growth of new blood vessels. The opposite also holds true. If a person is healthy, the balance is easily maintained, but in some disease states things get out of hand, in either direction—too many or too few new vessels. You see, tumors also need a blood supply. The nutrients and growth factors supplied by the new blood vessels allow tumors to grow. Because of this, the search for ways to destroy cancer cells is partly focused on anti-angiogenesis. But having too many blood vessels is not limited to tumors. Diseases of the eye (macular degeneration, for example) and chronic inflammatory diseases, such as rheumatoid arthritis, psoriasis, and periodontal disease are also characterized by proliferation of vascular tissue. (Polverini. 1995) And researchers at the University of British Columbia believe that Alzheimer’s disease may be related to hypervascularization. (Biron. 2011)
Substances that prevent the formation of new blood vessels have been around for awhile. Thalidomide is one of them. This drug caused quite a stir in the 1950’s and 60‘s, after it was found to cause skeletal birth defects. Prescribed as a sedative to prevent morning sickness, thalidomide caused thousands of congenital disorders before it was reined in. Because it has benefits for leprosy patients and some inflammatory and autoimmune disorders, it’s still available. Additionally, its antiangiogenic character makes it an appropriate choice for the treatment of multiple myeloma, a primary tumor of bone marrow. (Singhal. 1999) (Bamias. 2003) If thalidomide is able to interrupt the formation of new blood vessels, you can easily see how the development of a neonate can be disrupted.
To study the effects of antiangiogenic substances, some scientists have chosen fat as the experimental system because of its remodeling capacity. Here they have learned that the manufacture of new blood vessels is important to the viability of adipose tissue, and that if the neovascularization were halted, so would be the proliferation of fat cells. (Rupnick. 2002) This transfer of concept to tumor cells is encouraging. A signaling protein termed VEGF (vascular endothelial growth factor) stimulates the growth of new blood vessels, and it helps to restore the oxygen supply to tissues when blood circulation is inadequate. Its importance in embryonic development is obvious, but its overexpression can be problematic. Solid tumors need VEGF to grow beyond their normally limited size, so they make their own. On the other hand, the body makes angiogenic inhibitors, such as thrombospondin and angiostatin to keep tumors dormant. ( Huang. 2004) Besides thalidomide, there are numerous pharmaceuticals available to interrupt angiogenesis, including bevacizumab (Avastin®) and other monoclonal antibodies, the side effects of which offer a laundry list of ills, including cancer. (Hansel. 2010) How ironic! The majority of these drugs block the activity of VEGF, but there may be other angiogenic factors about which less is known.
Working on the antiangiogenesis strategy proposed by renowned cancer researcher, Judah Folkman, Dr. William Li, of the Angiogenesis Foundation in New York, looked beyond drugs and their costs and toxicity, and identified powerful antiangiogenic molecules in dietary sources. This suggests that dietary enlightenment could offer a safe, readily available, novel strategy for preventing cancer. (Folkman. 2006) (Li. 2012)
Dr. Li discovered that nature has loaded a number of foods, beverages and herbs with naturally occurring inhibitors of angiogenesis: berries, citrus fruits, cruciferous vegetables, mushrooms, tomatoes, red wine, green tea, parsley, garlic, turmeric and dark chocolate, among others. The laboratory names extracted from these foods include brassanin, curcumin, genistein, N-acetylcysteine, resveratrol, silymarin, and selenium. The last-named is the only antioxidant mineral. ( Li. 2012)
A study in India, at the Himalayan Institute of Medical Sciences, found aberrant angiogenesis to be factored in Alzheimer’s disease and AIDS, comparing the modulation of angiogenesis in this century to the antibiotics of the twentieth century. (Bisht. 2010) Sagar, Yance and Wong, working at the McMaster University Department of Medicine, in Ontario, added a litany of herbs to Dr. Li’s initial list, citing their antiangiogenic behavior as being engaged through several interdependent processes that include effects on gene expression and enzyme activities. Besides inhibiting the formation of new vascular tissue, these may directly hinder tumor progression and reduce metastasis by way of other actions, including the interruption of epidermal growth factor reception, the blocking of the cyclooxygenase-2 enzyme, and the obstruction of nuclear factor kappa-B transcription. The herbals, artemisia annua (Chinese wormwood), viscum album (European mistletoe), curcuma longa (curcumin), resveratrol, quercitin, ginger, Panax ginseng, and proanthocyanidin (grape seed extract) are among them. (Sagar, Yance and Wang. 2006)
Not only has a soy-based diet, but also the isolated soy isoflavone, genistein, exhibited anti-cancer properties, particularly in lines of melanoma and mammary carcinoma. As is the case with most non-drug treatments, effect is dose-dependent. Its behavior suggests interference with tumor cell migration. (Farina. 2006) The medicinal mushroom, Agaricus blazei Murrill, common to the tropical rain forests near Sao Paulo, Brazil, has traditionally been used to stimulate the immune system, to treat digestive and circulatory disorders, and to lower cholesterol. But its lipid fraction, ergosterol, which is converted to vitamin D2 when exposed to UV radiation, was found to reduce tumor growth significantly in sarcoma-bearing mice at doses of 400+ mg/kg without side effects, suggesting that either ergosterol or its metabolites inhibits tumor-induced neovascularization. (Takaku. 2001) This is the first report of ergosterol’s antiangiogenic character. Later study of this mushroom found additional antiangiogenic constituents. (Kimura. 2004)
Another popular medicinal mushroom is Ganoderma lucidum, used largely in East Asia. Its attributes include the induction of programmed cell death in tumors (apoptosis), accompanied by the inhibition of cell proliferation and suppression of cell migration, especially in prostate cancer, where VEGF was down-regulated. (Stanley. 2005) It is desirable to keep cancer growth stagnant for as long a time as possible. Black raspberry extract was able to do that, as identified in research at Louisiana State University, where investigators saw potent inhibition of angiogenesis and concomitant vessel growth. Gallic acid was pinpointed as a major agent, which worked best in conjugation with less potent fractions, the synergy of which has yet to be elucidated. (Zhijun. 2005)
By disrupting the growth of new vessels from pre-existing capillaries, the green tea catechin, epigallocatechin gallate (EGCG) interrupts cell tube formation in the angiogenesis process by stopping VEGF signals from reaching their receptors. (Rodriguez. 2006) Likewise, blueberries are antiangiogenic. But these little beauties also have the distinction of being able to regenerate rhodopsin, the ocular molecule responsible for turning light energy onto nerve signals. Chinese researchers also found that blueberries can help to forestall a few age-related chronic diseases, such as diabetes, hyperlipidemia, hypertension, neurodegeneration, and even obesity through its apoptosis, antioxidant and anti-inflammation effects. (Chen. 2010)
If there is a favorite among anti-cancer alternative treatments, curcumin might hog the spotlight. Chemoprevention—the use of chemicals to prevent the development of cancer—is a promising anti-cancer approach with limited side effects compared to traditional chemotherapy. Curcumin, isolated from the kitchen spice turmeric, demonstrates the capability of suppressing, retarding, and even inverting carcinogenesis. It is able to induce apoptosis in cancer cells without cytotoxic effects on healthy cells while inhibiting the formation of tumors. It is well tolerated and is selective for cancer cells. (Lopez-Lazaro. 2008) No definitive dose has been identified, but trials using up to 8,000 mg a day have found no adverse effects. Its particular effectiveness appears to lie in colon cancer lines (Johnson. 2007), but its antiproliferative effects may extend to others (Hanif. 1997) (Lopez-Lazaro. 2008) The military can win a war by cutting off the enemy’s supplies. Could the war on cancer do the same?
Bennewith KL, Dedhar S. Targeting hypoxic tumour cells to overcome metastasis. BMC Cancer. 2011 Nov 30;11(1):504.
Bamias A, Dimopoulos MA. Angiogenesis in human cancer: implications in cancer therapy. Eur J Intern Med. 2003 Dec;14(8):459-469.
Kaan E Biron, Dara L. Dickstein, Rayshad Gopaul, Wilfred A. Jefferies Amyloid Triggers Extensive Cerebral Angiogenesis Causing Blood Brain Barrier Permeability and Hypervascularity in Alzheimer's Disease PLoS ONE. 6(8); 31 Aug 2011: e 23789
Bisht M, Dhasmana DC, Bist SS. Angiogenesis: Future of pharmacological modulation. Indian J Pharmacol. 2010 Feb;42(1):2-8.
Chen CF, Li YD, Xu Z. Chemical principles and bioactivities of blueberry Yao Xue Xue Bao. 2010 Apr;45(4):422-9.
Annelyse Duvoix, Romain Blasius, Sylvie Delhalle, Michael Schnekenburger, et al Chemopreventive and therapeutic effects of curcumin Cancer Letters. 2005. 223: 181-190
Farina HG, Pomies M, Alonso DF, Gomez DE. Antitumor and antiangiogenic activity of soy isoflavone genistein in mouse models of melanoma and breast cancer. Oncol Rep. 2006 Oct;16(4):885-91.
Folkman J. Role of angiogenesis in tumor growth and metastasis. Semin Oncol. 2002 Dec;29(6 Suppl 16):15-8.
Folkman J. Antiangiogenesis in cancer therapy--endostatin and its mechanisms of action. Exp Cell Res. 2006 Mar 10;312(5):594-607.
Hanif R, Qiao L, Shiff SJ, Rigas B. Curcumin, a natural plant phenolic food additive, inhibits cell proliferation and induces cell cycle changes in colon adenocarcinoma cell lines by a prostaglandin-independent pathway. J Lab Clin Med. 1997 Dec;130(6):576-84.
Hansel TT, Kropshofer H, Singer T, Mitchell JA, George AJ. The safety and side effects of monoclonal antibodies. Nat Rev Drug Discov. 2010 Apr;9(4):325-38.
Huang Z, Bao SD. Roles of main pro- and anti-angiogenic factors in tumor angiogenesis. World J Gastroenterol. 2004; 10(4): 463-70
Johnson JJ, Mukhtar H. Curcumin for chemoprevention of colon cancer. Cancer Lett. 2007 Oct 8;255(2):170-81.
Joshi J, Ghaisas S, Vaidya A, Vaidya R, Kamat DV, Bhagwat AN, Bhide S. Early human safety study of turmeric oil (Curcuma longa oil) administered orally in healthy volunteers. J Assoc Physicians India. 2003 Nov;51:1055-60.
Kajdaniuk D, Marek B, Fołtyn W, Kos-Kudła B. Vascular endothelial growth factor (VEGF) in endocrinology and oncology. Endokrynol Pol. 2011;62(Supl. III):14-22.
Kimura Y, Kido T, Takaku T, Sumiyoshi M, Baba K. Isolation of an anti-angiogenic substance from Agaricus blazei Murill: its antitumor and antimetastatic actions. Cancer Sci. 2004 Sep;95(9):758-64.
Li WW, Li VW, Hutnik M, Chiou AS. Tumor angiogenesis as a target for dietary cancer prevention. J Oncol. 2012;2012:879623.
Polverini PJ. The pathophysiology of angiogenesis. Crit Rev Oral Biol Med. 1995;6(3):230-47.
López-Lázaro, Miguel Anticancer and carcinogenic properties of curcumin: Considerations for its clinical development as a cancer chemopreventive and chemotherapeutic agent Molecular Nutrition & Food Research. Supplement: Natural Products and Dietary Prevention of Cancer. Vol 52, Iss S1, pages S103–S127, June 2008
Rodriguez, S.K., Guo, W., Liu, L., Band, M.A., Paulson, E.K., Meydani, M. Green Tea Catechin, Epigallocatechin-3-Gallate (Egcg) Inhibits Vascular Endothelial Growth Factor Angiogenic Signaling by Disrupting the Formation of a Receptor Complex International Journal of Cancer. April 1, 2006; 118(7):1635-44.
Rupnick MA, Panigrahy D, Zhang CY, Dallabrida SM, Lowell BB, Langer R, Folkman MJ. Adipose tissue mass can be regulated through the vasculature. Proc Natl Acad Sci U S A. 2002 Aug 6;99(16):10730-5.
Sagar SM, Yance D, Wong RK. Natural health products that inhibit angiogenesis: a potential source for investigational new agents to treat cancer-Part 1. Curr Oncol. 2006 Feb;13(1):14-26.
Singhal S, Mehta J, Desikan R, Ayers D, Roberson P, Eddlemon P, Munshi N, Anaissie E, Wilson C, Dhodapkar M, Zeddis J, Barlogie B. Antitumor activity of thalidomide in refractory multiple myeloma. N Engl J Med. 1999 Nov 18;341(21):1565-71.
Stanley G, Harvey K, Slivova V, Jiang J, Sliva D. Ganoderma lucidum suppresses angiogenesis through the inhibition of secretion of VEGF and TGF-beta1 from prostate cancer cells. Biochem Biophys Res Commun. 2005 Apr 29;330(1):46-52.
Takaku T, Kimura Y, Okuda H. Isolation of an antitumor compound from Agaricus blazei Murill and its mechanism of action. J Nutr. 2001 May;131(5):1409-13.
Zhijun Liu, Joshua Schwimer, Dong Liu, Frank L. Greenway, Catherine T. Anthony, and Eugene A. Woltering Black Raspberry Extract and Fractions Contain Angiogenesis Inhibitors J. Agric. Food Chem., 2005, 53 (10), pp 3909–3915
*These statements have not been evaluated by the FDA. These products are not intended to treat, diagnose, cure, or prevent any disease.
January 01, 2012